Pfizer submitted application for emergency use of Covid vaccine

US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage. Pfizer has said the emergency use authorization application, that could start the marketing launch process early. In US, the coronavirus vaccine doses could be available as early as next month.

#COVID19 UPDATE: We will submit a request today to the @US_FDA for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group.

— Pfizer Inc. (@pfizer) November 20, 2020

What is emergency use authorization (EUA)?

Click here to learn more